Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 48252-48253 [2021-18514]

Download as PDF lotter on DSK11XQN23PROD with NOTICES1 48252 Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices Abstract: This rule prohibits, in certain circumstances, a federally insured credit union (FICU) from making golden parachute and indemnification payments to an institution-affiliated party (IAP). Section 750.4 prescribed written concurrence of the appropriate state supervisory authority, if applicable; § 750.5 covers recordkeeping requirements of permissible indemnification payments, and § 750.6 requires requests by a troubled FICU to make a severance or golden parachute payment to an IAP, to be submitted in writing to NCUA. The information will be used by the NCUA to determine whether an exception to the general prohibition on golden parachute payments should be approved. Affected Public: Private Sector: Notfor-profit institutions. Estimated Number of Respondents: 4. Estimated Number of Responses per Respondent: 2.25. Estimated Total Annual Responses: 9. Estimated Burden Hours per Response: 2.05. Estimated Total Annual Burden Hours: 19. Reason for Change: The number of respondents has been update to reflect current estimates and recordkeeping requirements prescribed under § 750.5 are added that were previously omitted. OMB Number: 3133–0197. Title: Safe Harbor; Treatment of Financial Assets Transferred in Connection with a Securitization or Participation. Type of Review: Extension of a currently approved collection. Abstract: Section 709.9 clarifies the conditions for a safe harbor for securitization or participation and sets forth safe harbor protections for securitizations that do not comply with the new accounting standards for off balance sheet treatment by providing for expedited access to the financial assets that are securitized if they meet the conditions defined in the rule. The conditions contained in the rule will serve to protect the National Credit Union Share Insurance Fund (NCUSIF) and NCUA’s interests as liquidating agent or conservator by aligning the conditions for the safe harbor with better and more sustainable lending practices by insured credit unions (FICUs). Affected Public: Private Sector: Notfor-profit institutions. Estimated Number of Respondents: 4. Estimated Number of Responses per Respondent: 9. Estimated Total Annual Responses: 36. VerDate Sep<11>2014 17:52 Aug 26, 2021 Jkt 253001 Estimated Burden Hours per Response: 14.28. Estimated Total Annual Burden Hours: 514. Request for Comments: Comments submitted in response to this notice will be summarized and included in the request for Office of Management and Budget approval. All comments will become a matter of public record. The public is invited to submit comments concerning: (a) Whether the collection of information is necessary for the proper execution of the function of the agency, including whether the information will have practical utility; (b) the accuracy of the agency’s estimate of the burden of the collection of information, including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of the information on the respondents, including the use of automated collection techniques or other forms of information technology. By Melane Conyers-Ausbrooks, Secretary of the Board, the National Credit Union Administration, on August 23, 2021. Dated: August 24, 2021. Dawn D. Wolfgang, NCUA PRA Clearance Officer. Minutes: May be obtained from the contact person listed above. Purpose of Meeting: To provide advice and recommendations to the National Science Foundation concerning support for polar research, education, infrastructure and logistics, and related activities. Agenda September 23, 2021; 10:30 a.m.–4:30 p.m. (Virtual) • COVID 19 Impacts • Advisory Committee Liaison Updates • Joint Session: Polar Programs (OPP) and Advisory Committee on Cyberinfrastructure (ACCI) • NSF GEO Activities Updates September 24, 2021; 10:30 a.m.–4:30 p.m. (Virtual) • Research Security and International Partnerships • Meeting with the NSF Director & Chief Operating Officer • NSF GEO Activities Updates • USAP Polar Vessel Requirements Updates • Discussion regarding Subcommittee on Diversity, Equity, & Inclusion Dated: August 23, 2021. Crystal Robinson, Committee Management Officer. [FR Doc. 2021–18405 Filed 8–26–21; 8:45 am] BILLING CODE 7555–01–P [FR Doc. 2021–18475 Filed 8–26–21; 8:45 am] BILLING CODE 7535–01–P NUCLEAR REGULATORY COMMISSION NATIONAL SCIENCE FOUNDATION Advisory Committee for Polar Programs; Notice of Meeting In accordance with the Federal Advisory Committee Act (Pub. L. 92– 463, as amended), the National Science Foundation (NSF) announces the following meeting: Name and Committee Code: Advisory Committee for Polar Programs (1130). Date and Time: September 23, 2021; 10:30 a.m.–4:30 p.m. September 24, 2021; 10:30 a.m.–4:30 p.m. Place: National Science Foundation, 2415 Eisenhower Avenue, Alexandria, Virginia 22314 | Virtual. Registration for the virtual meeting will be available two weeks prior to the meeting date and will be located on the website: https://www.nsf.gov/geo/opp/ advisory.jsp. Type of Meeting: Open. Contact Person: Beverly Walker, National Science Foundation, 2415 Eisenhower Avenue, Virginia 22314; Telephone: (703) 292–2614. PO 00000 Frm 00139 Fmt 4703 Sfmt 4703 Advisory Committee on the Medical Uses of Isotopes: Meeting Notice Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on October 4, 2021. A sample of agenda items to be discussed during the public session includes: (1) A discussion of the ACMUI’s review and analysis of medical events from fiscal years 2017 to 2020; (2) a discussion of the ACMUI’s subcommittee report on radionuclide generator knowledge and practice requirements; (3) a discussion of the ACMUI’s subcommittee report on emerging radiopharmaceutical therapy knowledge requirements in theranostics; (4) a discussion on production challenges for therapeutic radiopharmaceuticals; and (5) a discussion on the future of personalized dosimetry. The agenda is subject to SUMMARY: E:\FR\FM\27AUN1.SGM 27AUN1 Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices change. The current agenda and any updates will be available on the ACMUI’s Meetings and Related Documents web page at https:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2021.html or by emailing Ms. Kellee Jamerson at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Date and Time for Open Session: October 4, 2021, from 10:00 a.m. to 4:00 p.m. Date Webinar information October 4, 2021 Link: https:// usnrc.webex.com. Event number: 199 227 5195. lotter on DSK11XQN23PROD with NOTICES1 Date and Time for Closed Session: October 5, 2021, from 12:00 p.m. to 2:00 p.m. Eastern Standard Time. This session will be closed to conduct the ACMUI’s required annual training. Public Participation: The meeting will be held as a webinar using the WebEx meeting platform. Any member of the public who wishes to participate in any open sessions of this meeting should register in advance of the meeting by visiting the link and entering the event number(s) provided above. Upon successful registration, a confirmation email will be generated providing the telephone bridge line and a link to join the webinar on the day of the meeting. Members of the public should also monitor the NRC’s Public Meeting Schedule at https://www.nrc.gov/pmns/ mtg for any meeting updates. If there are any questions regarding the meeting, persons should contact Ms. Jamerson using the information below. Contact Information: Ms. Kellee Jamerson, email: Kellee.Jamerson@ nrc.gov, telephone: 301–415–7408. Conduct of the Meeting Darlene F. Metter, M.D. will chair the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson using the contact information listed above. All submittals must be received by the close of business on September 28, 2021, three business days before the meeting, and must pertain to the topics on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the Chairman. VerDate Sep<11>2014 17:52 Aug 26, 2021 Jkt 253001 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2021.html on or about November 19, 2021. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Jamerson of their planned participation. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. app); and the Commission’s regulations in title 10 of the Code of Federal Regulations, part 7. Dated at Rockville, Maryland this 24th day of August, 2021. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2021–18514 Filed 8–26–21; 8:45 am] BILLING CODE 7590–01–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–92728; File No. SR– PEARL–2021–38] Self-Regulatory Organizations: MIAX PEARL, LLC; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change To Amend the MIAX Pearl Options Fee Schedule To Adjust the Options Regulatory Fee August 23, 2021. Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (the ‘‘Act’’),1 and Rule 19b–4 thereunder,2 notice is hereby given that on August 12, 2021, MIAX PEARL, LLC (‘‘MIAX Pearl’’ or ‘‘Exchange’’) filed with the Securities and Exchange Commission (the ‘‘Commission’’) the proposed rule change as described in Items I, II, and III below, which Items have been prepared by the Exchange. The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. I. Self-Regulatory Organization’s Statement of the Terms of Substance of the Proposed Rule Change The Exchange is filing a proposal to amend the MIAX Pearl Options Fee Schedule (the ‘‘Fee Schedule’’) to adjust the Options Regulatory Fee (‘‘ORF’’). The text of the proposed rule change is available on the Exchange’s website at 1 15 2 17 PO 00000 U.S.C. 78s(b)(1). CFR 240.19b–4. Frm 00140 Fmt 4703 Sfmt 4703 48253 https://www.miaxoptions.com/rulefilings/pearl at MIAX Pearl’s principal office, and at the Commission’s Public Reference Room. II. Self-Regulatory Organization’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change In its filing with the Commission, the Exchange included statements concerning the purpose of and basis for the proposed rule change and discussed any comments it received on the proposed rule change. The text of these statements may be examined at the places specified in Item IV below. The Exchange has prepared summaries, set forth in sections A, B, and C below, of the most significant aspects of such statements. A. Self-Regulatory Organization’s Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change 1. Purpose Currently, the Exchange assesses ORF in the amount of $0.0028 per contract side. The Exchange proposes to reduce the amount of ORF from $0.0028 per contract side to $0.0018 per contract side in order to help ensure that revenue collected from the ORF, in combination with other regulatory fees and fines, does not exceed the Exchange’s total regulatory costs. The Exchange’s proposed change to the ORF should balance the Exchange’s regulatory revenue against the anticipated regulatory costs. The Exchange initially filed this proposal on July 30, 2021 (SR– PEARL–2021–37) and withdrew such filing on August 12, 2021. The Exchange proposes to implement the fee change effective August 12, 2021. Collection of ORF Currently, the Exchange assesses the per-contract ORF to each Member 3 for all options transactions, including Mini Options, cleared or ultimately cleared by the Member, which are cleared by the Options Clearing Corporation (‘‘OCC’’) in the ‘‘customer’’ range,4 regardless of the exchange on which the transaction occurs. The ORF is collected 3 The term ‘‘Member’’ means an individual or organization that is registered with the Exchange pursuant to Chapter II of Exchange Rules for purposes of trading on the Exchange as an ‘‘Electronic Exchange Member’’ or ‘‘Market Maker.’’ Members are deemed ‘‘members’’ under the Exchange Act. See the Definitions Section of the Fee Schedule and Exchange Rule 100. 4 Exchange participants must record the appropriate account origin code on all orders at the time of entry in order. The Exchange represents that it has surveillances in place to verify that Members mark orders with the correct account origin code. E:\FR\FM\27AUN1.SGM 27AUN1

Agencies

NUCLEAR REGULATORY COMMISSION

[Federal Register Volume 86, Number 164 (Friday, August 27, 2021)]
[Notices]
[Pages 48252-48253]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18514]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on October 4, 2021. A sample of agenda items to be discussed 
during the public session includes: (1) A discussion of the ACMUI's 
review and analysis of medical events from fiscal years 2017 to 2020; 
(2) a discussion of the ACMUI's subcommittee report on radionuclide 
generator knowledge and practice requirements; (3) a discussion of the 
ACMUI's subcommittee report on emerging radiopharmaceutical therapy 
knowledge requirements in theranostics; (4) a discussion on production 
challenges for therapeutic radiopharmaceuticals; and (5) a discussion 
on the future of personalized dosimetry. The agenda is subject to

[[Page 48253]]

change. The current agenda and any updates will be available on the 
ACMUI's Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html or by emailing Ms. 
Kellee Jamerson at the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Session: October 4, 2021, from 10:00 a.m. to 
4:00 p.m.

------------------------------------------------------------------------
                 Date                          Webinar information
------------------------------------------------------------------------
October 4, 2021.......................  Link: https://usnrc.webex.com.
                                        Event number: 199 227 5195.
------------------------------------------------------------------------

    Date and Time for Closed Session: October 5, 2021, from 12:00 p.m. 
to 2:00 p.m. Eastern Standard Time. This session will be closed to 
conduct the ACMUI's required annual training.
    Public Participation: The meeting will be held as a webinar using 
the WebEx meeting platform. Any member of the public who wishes to 
participate in any open sessions of this meeting should register in 
advance of the meeting by visiting the link and entering the event 
number(s) provided above. Upon successful registration, a confirmation 
email will be generated providing the telephone bridge line and a link 
to join the webinar on the day of the meeting. Members of the public 
should also monitor the NRC's Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting updates. If there are any 
questions regarding the meeting, persons should contact Ms. Jamerson 
using the information below.
    Contact Information: Ms. Kellee Jamerson, email: 
[email protected], telephone: 301-415-7408.

Conduct of the Meeting

    Darlene F. Metter, M.D. will chair the meeting. Dr. Metter will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson using the contact information listed 
above. All submittals must be received by the close of business on 
September 28, 2021, three business days before the meeting, and must 
pertain to the topics on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2021.html on or about November 19, 2021.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Jamerson of their planned 
participation.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. app); and the Commission's regulations in title 
10 of the Code of Federal Regulations, part 7.

    Dated at Rockville, Maryland this 24th day of August, 2021.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2021-18514 Filed 8-26-21; 8:45 am]
BILLING CODE 7590-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.